Health Care: Drugs

Anacor Pharmaceuticals Inc (ANAC: NASDAQ)

$24.54 -0.16 | -0.65%
09/23/14 - 02:10 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 17.23M 10.74M 20.31M 27.82M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 17.23M 10.74M 20.31M 27.82M
Selling, General, and Administrative Expenses 20.65M 11.61M 10.55M 7.45M
Research & Development 46.56M 52.32M 56.10M 29.87M
Operating Income before D & A (EBITDA) -49.98M -53.19M -46.34M -9.49M
Depreciation & Amortization 1.65M 1.70M 2.36M 1.53M
Interest Income 55.00K 72.00K 148.00K 25.00K
Other Income - Net -2.05M -53.00K -353.00K 1.42M
Special Income / Charges 142.50M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 88.87M -54.87M -48.91M -9.58M
Interest Expense 4.05M 2.91M 1.40M 2.00M
Pre-Tax Income 84.82M -57.78M -50.31M -11.58M
Income Taxes 1.71M 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 84.76M -56.09M -47.94M -10.06M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 84.76M -56.09M -47.94M -10.06M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 84.76M -56.09M -47.94M -10.06M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-57.74M -56.09M -47.94M -10.06M
Preferred Dividends
Net Income Available To Common 84.76M -56.09M -47.94M -10.06M
Basic EPS from Continuing Ops. 2.16 -1.76 -1.71 -0.54
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.16 -1.76 -1.71 -0.54
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.16 -1.76 -1.71 -0.54
Basic Normalized Net Income/Share -1.47 -1.76 -1.71 -0.54
EPS fr Continuing Ops. 2.10 -1.76 -1.71 -0.54
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.10 -1.76 -1.71 -0.54
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.10 -1.76 -1.71 -0.54
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.43 -1.76 -1.71 -0.54
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ANAC

Latest ANAC Headlines from TheStreet

More Financial News for ANAC

Press Releases for ANAC

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter